Related Experiment Video
Updated: Jan 23, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
IR-783 inhibits breast cancer cell proliferation and migration by inducing mitochondrial fission
Pantong Li1, Yu Liu1, Wuyi Liu2
1Department of Pharmacy, The University-Town Hospital of Chongqing Medical University, Chongqing 401331, P.R. China.
Abstract:
IR‑783, a near‑infrared heptamethine cyanine dye, has been reported to possess cancer targeting and anticancer effects; Ηowever, the molecular mechanism by which IR‑783 exhibits anti‑breast cancer activity is unclear. In the present study, the inhibitory effects of IR‑783 on the proliferation and migration of breast cancer cells were investigated. Our results revealed that IR‑783 inhibited MDA‑MB‑231 and MCF‑7 cell proliferation in a dose‑ and time‑dependent manner by inducing cell cycle arrest at the G0/G1 phase. In addition, a Transwell assay demonstrated that IR‑783 treatment suppressed the migratory ability of MDA‑MB‑231 and MCF‑7 cells. Furthermore, IR‑783 treatment decreased the expression levels of matrix metalloproteinase (MMP)‑2 and MMP‑9 in MDA‑MB‑231 cells. Furthermore, IR‑783 induced MDA‑MB‑231 and MCF‑7 cell mitochondrial fission, and also decreased the levels of ATP. This was accompanied with a decrease in polymerized filamentous actin, which is the fundamental component of filopodia at the cell surface. Collectively, the results of the present study demonstrated that IR‑783 inhibited the proliferation and migration of MDA‑MB‑231 and MCF‑7 cells by inducing mitochondrial fission and subsequently decreasing ATP levels, resulting in cell cycle arrest and filopodia formation suppression. These findings suggest that IR‑783 may be developed into an effective novel drug for treating breast cancer.
Insights
IR-783, a near-infrared dye, effectively inhibits breast cancer cell proliferation and migration. It works by inducing mitochondrial fission, reducing ATP levels, and causing cell cycle arrest, suggesting its potential as a novel breast cancer therapeutic.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- IR-783, a near-infrared heptamethine cyanine dye, shows promise for cancer targeting and treatment.
- The precise molecular mechanisms underlying IR-783's anti-breast cancer effects remain largely unelucidated.
Purpose of the Study:
- To investigate the inhibitory effects of IR-783 on breast cancer cell proliferation and migration.
- To elucidate the molecular mechanisms responsible for IR-783's anti-breast cancer activity.
Main Methods:
- Cell proliferation assays were performed on MDA-MB-231 and MCF-7 cell lines.
- Cell migration was assessed using Transwell assays.
- Mitochondrial function, ATP levels, and actin polymerization were analyzed post-IR-783 treatment.
Main Results:
- IR-783 demonstrated dose- and time-dependent inhibition of MDA-MB-231 and MCF-7 cell proliferation by inducing G0/G1 cell cycle arrest.
- IR-783 significantly suppressed the migratory capacity of both cell lines and reduced matrix metalloproteinase (MMP)-2 and MMP-9 expression in MDA-MB-231 cells.
- IR-783 induced mitochondrial fission, decreased ATP levels, and reduced polymerized filamentous actin, inhibiting filopodia formation.
Conclusions:
- IR-783 inhibits breast cancer cell proliferation and migration through mitochondrial fission and subsequent ATP depletion, leading to cell cycle arrest and suppressed filopodia formation.
- These findings highlight IR-783 as a potential novel therapeutic agent for breast cancer treatment.
Related Concept Videos
Nuclear Fission
Cancer Cell Migration through Invadopodia
Binary Fission
Binary Fission
Cell Migration
Cell Migration

